Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
Covalent peptidomimetic protease inhibitors have gained a lot of attention in drug development in recent years. They are designed to covalently bind the catalytically active amino acids through electrophilic groups called warheads. Covalent inhibition has an advantage in terms of pharmacodynamic pro...
Main Authors: | Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V. Gonzàlez, Bernd Engels, Tanja Schirmeister |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7226 |
Similar Items
-
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
by: Fangjiao Huang, et al.
Published: (2022-11-01) -
Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
by: Zheng Zhao, et al.
Published: (2022-10-01) -
Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres
by: Patrick Müller, et al.
Published: (2024-01-01) -
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery
by: Chiara Borsari, et al.
Published: (2023-05-01) -
Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
by: Patrycja Ledwoń, et al.
Published: (2021-06-01)